Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

Por Sawaki, Akira, Kanda, Tatsuo, Komatsu, Yoshito, Nishida, Toshirou
Publicado em 2014

Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates

Por Mizushima, Takuji, Sugiyama, Toshiro, Komatsu, Yoshito, Ishizuka, Jun, Kato, Mototsgu, Asaka, Masahiro
Publicado em 2001

Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center E...

Por Muranaka, Tetsuhito, Yuki, Satoshi, Komatsu, Yoshito, Sawada, Kentaro, Harada, Kazuaki, Kawamoto, Yasuyuki, Nakatsumi, Hiroshi, Sakamoto, Naoya
Publicado no J Gastric Cancer (2016)

Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial

Por Komatsu, Yoshito, Doi, Toshihiko, Sawaki, Akira, Kanda, Tatsuo, Yamada, Yasuhide, Kuss, Iris, Demetri, George D, Nishida, Toshirou
Publicado no Int J Clin Oncol (2015)

Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor

Por Komatsu, Yoshito, Ohki, Emiko, Ueno, Naomi, Yoshida, Ai, Toyoshima, Yasuharu, Ueda, Eiji, Houzawa, Hiroyuki, Togo, Kanae, Nishida, Toshirou
Publicado no Jpn J Clin Oncol (2015)

Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic...

Por Komatsu, Yoshito, Yoshino, Takayuki, Yamazaki, Kentaro, Yuki, Satoshi, Machida, Nozomu, Sasaki, Takahide, Hyodo, Ichinosuke, Yachi, Yutaka, Onuma, Hiroshi, Ohtsu, Atsushi
Publicado em 2013

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

Por Sawaki, Akira, Yamada, Yasuhide, Komatsu, Yoshito, Kanda, Tatsuo, Doi, Toshihiko, Koseki, Masato, Baba, Hideo, Sun, Yu-Nien, Murakami, Koji, Nishida, Toshirou
Publicado em 2009

Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

Por Doi, Toshihiko, Boku, Narikazu, Kato, Ken, Komatsu, Yoshito, Yamaguchi, Kensei, Muro, Kei, Hamamoto, Yasuo, Sato, Atsushi, Koizumi, Wasaburo, Mizunuma, Nobuyuki, Takiuchi, Hiroya
Publicado em 2010

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

Por Hofheinz, Ralf-Dieter, Deplanque, Gaël, Komatsu, Yoshito, Kobayashi, Yoshimitsu, Ocvirk, Janja, Racca, Patrizia, Guenther, Silke, Zhang, Jun, Lacouture, Mario E., Jatoi, Aminah
Publicado no Oncologist (2016)

Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first...

Por Komatsu, Yoshito, Ishioka, Chikashi, Shimada, Ken, Yamada, Yasuhide, Gamoh, Makio, Sato, Atsushi, Yamaguchi, Tatsuro, Yuki, Satoshi, Morita, Satoshi, Takahashi, Shin, Goto, Rei, Kurihara, Minoru
Publicado no BMC Cancer (2015)

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Por Yoshino, Takayuki, Komatsu, Yoshito, Yamada, Yasuhide, Yamazaki, Kentaro, Tsuji, Akihito, Ura, Takashi, Grothey, Axel, Van Cutsem, Eric, Wagner, Andrea, Cihon, Frank, Hamada, Yoko, Ohtsu, Atsushi
Publicado no Invest New Drugs (2014)

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition

Por Sato, Fumiyuki, Kubota, Yoshimasa, Natsuizaka, Mitsuteru, Maehara, Osamu, Hatanaka, Yutaka, Marukawa, Katsuji, Terashita, Katsumi, Suda, Goki, Ohnishi, Shunsuke, Shimizu, Yuichi, Komatsu, Yoshito, Ohashi, Shinya, Kagawa, Shingo, Kinugasa, Hideaki, Whelan, Kelly A, Nakagawa, Hiroshi, Sakamoto, Naoya
Publicado no Cancer Biol Ther (2015)

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

Por Yamaguchi, Kensei, Sawaki, Akira, Doi, Toshihiko, Satoh, Taroh, Yamada, Yasuhide, Omuro, Yasushi, Nishina, Tomohiro, Boku, Narikazu, Chin, Keisho, Hamamoto, Yasuo, Takiuchi, Hiroya, Komatsu, Yoshito, Saji, Shigehira, Koizumi, Wasaburo, Miyata, Yoshinori, Sato, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Ohtsu, Atsushi
Publicado em 2012

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA st...

Por Yamaguchi, Kensei, Sawaki, Akira, Doi, Toshihiko, Satoh, Taroh, Yamada, Yasuhide, Omuro, Yasushi, Nishina, Tomohiro, Boku, Narikazu, Chin, Keisho, Hamamoto, Yasuo, Takiuchi, Hiroya, Komatsu, Yoshito, Saji, Shigehira, Koizumi, Wasaburo, Miyata, Yoshinori, Sato, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Ohtsu, Atsushi
Publicado em 2012

Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron

Por Komatsu, Yoshito, Okita, Kenji, Yuki, Satoshi, Furuhata, Tomohisa, Fukushima, Hiraku, Masuko, Hiroyuki, Kawamoto, Yasuyuki, Isobe, Hiroshi, Miyagishima, Takuto, Sasaki, Kazuaki, Nakamura, Michio, Ohsaki, Yoshinobu, Nakajima, Junta, Tateyama, Miki, Eto, Kazunori, Minami, Shinya, Yokoyama, Ryoji, Iwanaga, Ichiro, Shibuya, Hitoshi, Kudo, Mineo, Oba, Koji, Takahashi, Yasuo
Publicado no Cancer Sci (2015)

A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma

Por Maehara, Osamu, Sato, Fumiyuki, Natsuizaka, Mitsuteru, Asano, Ayaka, Kubota, Yoshimasa, Itoh, Jun, Tsunematsu, Seiji, Terashita, Katsumi, Tsukuda, Yoko, Nakai, Masato, Sho, Takuya, Suda, Goki, Morikawa, Kenichi, Ogawa, Koji, Chuma, Makoto, Nakagawa, Koji, Ohnishi, Shunsuke, Komatsu, Yoshito, Whelan, Kelly A, Nakagawa, Hiroshi, Takeda, Hiroshi, Sakamoto, Naoya
Publicado no Cancer Biol Ther (2015)

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Por Satoh, Taroh, Lee, Kyung Hee, Rha, Sun Young, Sasaki, Yasutsuna, Park, Se Hoon, Komatsu, Yoshito, Yasui, Hirofumi, Kim, Tae-You, Yamaguchi, Kensei, Fuse, Nozomu, Yamada, Yasuhide, Ura, Takashi, Kim, Si-Young, Munakata, Masaki, Saitoh, Soh, Nishio, Kazuto, Morita, Satoshi, Yamamoto, Eriko, Zhang, Qingwei, Kim, Jung-mi, Kim, Yeul Hong, Sakata, Yuh
Publicado no Gastric Cancer (2014)